GENELUX CORPORATION Capital Expenditures
GENELUX CORPORATION (GNLX) reported Capital Expenditures of $2.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- GENELUX CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.53M, a 1232.17% increase year-over-year.
- GENELUX CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $921.00K, a 2970.00% increase year-over-year.
- GENELUX CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $436.00K, a 354.17% increase year-over-year.
- GENELUX CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $517.00K, a 1814.81% increase year-over-year.
- GENELUX CORPORATION payments to acquire property, plant, and equipment for fiscal 2025 was $1.10M, a 188.19% increase from fiscal 2024.
- GENELUX CORPORATION payments to acquire property, plant, and equipment for fiscal 2024 was $381.00K, a 62.83% decline from fiscal 2023.
- GENELUX CORPORATION payments to acquire property, plant, and equipment for fiscal 2023 was $1.02M, a 1991.84% increase from fiscal 2022.
- GENELUX CORPORATION payments to acquire property, plant, and equipment for fiscal 2022 was $49.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.45M 10-Q · filed 2026-08-13 | $2.89M derived: sum of 3 quarters · filed 2026-08-13 | $3.41M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $921.00K 10-Q · filed 2026-05-07 | $1.36M derived: sum of 2 quarters · filed 2026-05-07 | $1.87M derived: sum of 3 quarters · filed 2026-05-07 | $1.99M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $436.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $953.00K derived: sum of 2 quarters · filed 2026-03-19 | $1.07M derived: sum of 3 quarters · filed 2026-08-13 | $1.10M 10-K · filed 2026-03-19 |
| 2025-09-30 | $517.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $632.00K derived: sum of 2 quarters · filed 2026-08-13 | $662.00K 10-Q · filed 2025-11-05 | $758.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $145.00K 10-Q · filed 2026-08-13 | $241.00K derived: sum of 3 quarters · filed 2026-08-13 | $268.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $30.00K 10-Q · filed 2026-05-07 | $126.00K derived: sum of 2 quarters · filed 2026-05-07 | $153.00K derived: sum of 3 quarters · filed 2026-05-07 | $381.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $123.00K derived: sum of 2 quarters · filed 2026-03-19 | $351.00K derived: sum of 3 quarters · filed 2026-03-19 | $381.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $255.00K derived: sum of 2 quarters · filed 2025-11-05 | $285.00K 10-Q · filed 2025-11-05 | $528.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $258.00K 10-Q · filed 2025-08-07 | $501.00K derived: sum of 3 quarters · filed 2025-08-07 | $778.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $30.00K 10-Q · filed 2025-05-06 | $273.00K derived: sum of 2 quarters · filed 2025-05-06 | $550.00K derived: sum of 3 quarters · filed 2025-05-06 | $946.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $520.00K derived: sum of 2 quarters · filed 2025-03-28 | $916.00K derived: sum of 3 quarters · filed 2025-03-28 | $1.02M 10-K · filed 2025-03-28 |
| 2023-09-30 | $277.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $673.00K derived: sum of 2 quarters · filed 2024-11-14 | $782.00K 10-Q · filed 2024-11-14 | $782.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $396.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $505.00K 10-Q · filed 2024-08-14 | $505.00K derived: sum of 3 quarters · filed 2024-08-14 | $538.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $109.00K 10-Q · filed 2024-05-09 | $109.00K derived: sum of 2 quarters · filed 2024-05-09 | $142.00K derived: sum of 3 quarters · filed 2024-05-09 | $143.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $33.00K derived: sum of 2 quarters · filed 2024-03-29 | $34.00K derived: sum of 3 quarters · filed 2024-03-29 | $49.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $34.00K derived: sum of 2 quarters · filed 2023-11-14 | $49.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $16.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $15.00K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |